Basel, 01 June 2018 European Commission approves Roche’s Perjeta for post-surgery treatment of HER2-positive early breast cancer at high risk of recurrence An important new treatment option has been approved for patients in Europe with HER2-positive early breast cancer at high risk of recurrence in a setting where the goal of treatment is cure High... Read more
25 May 2018 – The Board of Spectris plc (SXS: LSE), the productivity-enhancing instrumentation and controls company, announces that it has been informed by John O’Higgins of his intention to retire from the Board in the course of the next twelve months. John will remain as Chief Executive until a replacement is in place and... Read more
NOTICE OF THE 155TH ANNUAL GENERAL MEETING OF SHAREHOLDERS Read more
FY2017 Operating Results & Financial Position Read more
Process optimization and improved output with ZEISS microscopes Customer Story Until recently, additive manufacturing (AM) was thought to have value solely in prototyping new products or designs. Today, however, it is evolving into a game changing production technology. From medical implants to aircraft turbines – there is a wide range of potential applications for industrial 3D printed... Read more
Process optimization and improved output with ZEISS microscopes Customer Story Until recently, additive manufacturing (AM) was thought to have value solely in prototyping new products or designs. Today, however, it is evolving into a game changing production technology. From medical implants to aircraft turbines – there is a wide range of potential applications for industrial 3D printed... Read more
CHELMSFORD, Mass., May 7, 2018 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS), a leading worldwide provider of automated and cryogenic solutions for multiple markets including semiconductor manufacturing and life sciences, announced today that it will host its 2018 Analyst and Investor Day on Tuesday, May 22, 2018 in New York City. The conference will feature... Read more
WALTHAM, Mass., April 30, 2018 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will host its 2018 Analyst Meeting on Wednesday, May 23, starting at 9:00 a.m. (ET), at the Mandarin Oriental New York, 80 Columbus Circle at 60th Street, in New York City. The meeting... Read more
Basel, 27 April 2018 CHMP recommends EU approval of Roche’s Perjeta for post-surgery treatment of HER2-positive early breast cancer at high risk of recurrence In the large phase III APHINITY study, the combination of Perjeta, Herceptin and chemotherapy significantly reduced the risk of invasive breast cancer recurrence or death by 19% compared to Herceptin and... Read more
Basel, 27 April 2018 CHMP recommends EU approval of Roche’s Perjeta for post-surgery treatment of HER2-positive early breast cancer at high risk of recurrence In the large phase III APHINITY study, the combination of Perjeta, Herceptin and chemotherapy significantly reduced the risk of invasive breast cancer recurrence or death by 19% compared to Herceptin and... Read more